News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Photo collage of Ibrahim Halil Sahin and Alison Kanski taken from X
Jun 10, 2024, 04:49

Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski

Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of Medicine, shared a post on X:

“I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski Precision Oncology News!

Immunotherapy has revolutionized the management of patients with MSI-H CRC and will continue to do so!”

Ibrahim Halil Sahin

Source: Ibrahim Halil Sahin/X

Alison Kanski cancer Cancer Management cancer treatment colorectal cancer Dostarlimab Hematology Oncology Ibrahim Halil Sahin immunotherapy innovative cancer therapies Medical Advancements MSI-H CRC neoadjuvant rectal cancer study OncoDaily Oncology oncology discussion oncology research Precision Medicine Precision Oncology News Research University of Pittsburgh School of Medicine
Special Coverage
Blog
Mar 20, 2025, 17:47
Dennis Slamon on the pioneering work behind Herceptin’s FDA approval - NFCR
Blog
Mar 20, 2025, 17:37
Douglas Flora: Breaking down how AI is reshaping oncology care
Blog
Mar 20, 2025, 17:29
Enes Erul: Excited to be part of the ESO College Strategy Working Group
Blog
Mar 20, 2025, 17:26
What has the EU Cancer Plan achieved? Key questions addressed at EFPIA’s event - ECO
Positive
Mar 20, 2025, 17:08
Zainab Shinkafi-Bagudu was honored with an award by the Healthcare Federation of Nigeria
Blog
Mar 20, 2025, 16:59
Douglas Flora: What sets our National Oncology Conference apart?
Science
Mar 20, 2025, 15:51
Liang Cheng: Current androgen receptor antagonists under investigation for resistant prostate cancer
Blog
Mar 20, 2025, 15:25
Norman Ng: China’s R and D of PD-1 Immunotherapy Drugs - A Future Hope for Hong Kong?
Blog
Mar 20, 2025, 15:17
Dean Crowe: $75 MILLION for kids, teens, and young adults fighting cancer
Blog
Mar 20, 2025, 14:47
Eric Zwanenburg: The Princess Máxima Center and Google Cloud are developing an AI tool called Capricorn
Blog
Mar 20, 2025, 11:46
What happens when women not only have a seat at the table but also shape the agenda? - Kearney
Blog
Mar 20, 2025, 11:39
Susanna Fletcher Greer: Understanding cellular communication in colorectal adenocarcinoma